Dear Dr. Roach: I’m a healthy 50-year-old woman. I asked my doctor to test me for Lipoprotein(a) after reading about it. My level was high, at 41 mg/dL. My doctor told me that it didn’t need to be ...

Jeffrey Frist was getting desperate. Diagnosed with familial hypercholesterolemia (FH) in 2012 after his first heart attack the year before, he had experienced a cardiovascular event every 11 months ...

Share on Pinterest A new study suggests elevated lipoprotein(a) levels are linked to residual cardiovascular risk. Image credit: Evgeniia Siiankovskaia/Stocksy A new study suggests that high ...

Following these positive 36-week results, Silence Therapeutics plans to announce 48-week results of the ongoing ALPACAR-360 study in Q2 of 2024. Silence Therapeutics has released promising findings ...

DEAR DR. ROACH: I’m a healthy 50-year-old woman. I asked my doctor to test me for Lipoprotein(a) after reading about it. My level was high, at 41 mg/dL. My doctor told me that it didn’t need to be ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

Muvalaplin, an oral, once-daily treatment that inhibits lipoprotein(a) formation via a novel mechanism, achieved positive results in a 12-week Phase 2 study These data were published in the Journal of ...

Today is Lipoprotein (a) Awareness Day, and it’s a great opportunity to discuss lipids and howlipoprotein (a) might differ from your general understanding of how cholesterol works in our bodies.

SAN CARLOS, Calif.--(BUSINESS WIRE)--Lipoprotein(a) Foundation: Lipoprotein(a), also known as Lp(a), is currently the strongest monogenetic risk factor for coronary heart disease and aortic stenosis.

Dear Dr. Roach: I'm a healthy 50-year-old woman. I asked my doctor to test me for Lipoprotein(a) after reading about it. My level was high, at 41 mg/dL. My doctor told me that it didn't need to be ...